tradingkey.logo

Caris Life Sciences Inc

CAI
22.000USD
+0.750+3.53%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
6.21BCap. mercado
PérdidaP/E TTM

Caris Life Sciences Inc

22.000
+0.750+3.53%

Más Datos de Caris Life Sciences Inc Compañía

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Información de Caris Life Sciences Inc

Símbolo de cotizaciónCAI
Nombre de la empresaCaris Life Sciences Inc
Fecha de salida a bolsaJun 18, 2025
Director ejecutivoHalbert (David Dean)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección750 W. John Carpenter Freeway
CiudadIRVING
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75039
Teléfono18667718946
Sitio Webhttps://www.carislifesciences.com/
Símbolo de cotizaciónCAI
Fecha de salida a bolsaJun 18, 2025
Director ejecutivoHalbert (David Dean)

Ejecutivos de Caris Life Sciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
213.55M
98.49%
International
3.28M
1.51%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 31 de ene
Actualizado: sáb., 31 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Otro
33.40%
Accionistas
Accionistas
Proporción
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Otro
33.40%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
48.48%
Investment Advisor
21.18%
Hedge Fund
11.06%
Private Equity
10.54%
Investment Advisor/Hedge Fund
5.08%
Pension Fund
0.53%
Research Firm
0.29%
Sovereign Wealth Fund
0.13%
Family Office
0.02%
Otro
2.70%

Participación institucional

Actualizado: mié., 21 de ene
Actualizado: mié., 21 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
228
134.49M
38.87%
--
2025Q4
258
136.99M
48.55%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Halbert (David D)
122.76M
43.51%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.64%
--
--
Sep 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.18%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.68%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.59%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
9.58M
3.39%
+963.04K
+11.18%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.03M
2.84%
+721.77K
+9.88%
Sep 30, 2025
Braidwell LP
7.32M
2.59%
--
--
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.92M
2.45%
+154.50K
+2.29%
Sep 30, 2025
Silver Lake Partners
5.29M
1.88%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
Ver más
ARK Genomic Revolution ETF
Proporción0.67%
Texas Capital Texas Small Cap Equity Index ETF
Proporción0.52%
Renaissance IPO ETF
Proporción0.43%
RiverNorth Patriot ETF
Proporción0.3%
Franklin Genomic Advancements ETF
Proporción0.29%
Invesco Russell 1000 Equal Weight ETF
Proporción0.08%
Inspire 500 ETF
Proporción0.07%
T Rowe Price Small-Mid Cap ETF
Proporción0.05%
Texas Capital Texas Equity Index ETF
Proporción0.04%
Fidelity Nasdaq Composite Index ETF
Proporción0.02%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI